Naloxone Hydrochloride Injection
Product Images NDC 43598-750

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 43598-750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Naloxone Hydrochloride Injection USP 2 mg/2 mL (1 mg/mL) carton label for a single-dose disposable prefilled syringe. The label shows the product name, strength, dosage form, and usage routes (intravenous, intramuscular, subcutaneous). It includes directions for syringe assembly and use, manufacturer Dr. Reddy's Laboratories, Inc., and warnings about single use and storage conditions. The NDC is 43598-750.*

FDA Label Image

Carton-2 (Carton2)

Packaging label for Naloxone Hydrochloride Injection, USP 2 mg/2 mL (1 mg/mL) prefilled syringe by Dr. Reddy's Laboratories, Inc. The carton contains 10 single-dose disposable prefilled syringes for intravenous, intramuscular, or subcutaneous use. The label includes dosage strength, administration route, storage instructions, and syringe assembly directions.*

FDA Label Image

Container Label (Container)

Label for Naloxone Hydrochloride Injection, USP 1 mg/2 mL single-dose vial, manufactured by Dr. Reddy's Laboratories, Inc. The label includes volume measurement marks in milliliters, dosing instructions, and a barcode. It states the product is for intramuscular, intravenous, or subcutaneous injection and includes the product NDC 43598-750-11.*

FDA Label Image

Figure1 (Figure1)

An instructional diagram showing a hand removing a cap from the tip of a syringe. The syringe tip and cap are labeled to indicate the components. The image illustrates the step of removing the protective cap from a syringe before use.*

FDA Label Image

Figure2 (Figure2)

Illustration showing two hands preparing an injection: the left hand holding a sterile needle pack being opened, and the right hand twisting the cap off a prefilled syringe. This instructional image likely demonstrates the steps to prepare a Naloxone Hydrochloride injection.*

FDA Label Image

Figure3 (Figure3)

An instructional diagram showing a hand opening a safety cap or needle cover on an injection device, with arrows indicating the motion to remove the cover. The image suggests preparation steps for an injection. No specific textual information is visible.*

FDA Label Image

Figure4 (Figure4)

Illustration showing the preparation of a syringe for injection. A hand holds the syringe with the needle cap flipped open, while the other hand flicks the syringe barrel upward, presumably to remove air bubbles and ensure proper medication delivery for Naloxone Hydrochloride injection.*

FDA Label Image

Figure5 (Figure5)

An instructional diagram showing three different methods of activating a syringe device: finger activation, thumb activation, and surface activation. Each method is illustrated with a hand holding and pressing the device, with arrows indicating the direction of motion for activation.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Naloxone Hydrochloride, indicating the molecular arrangement and key functional groups, with annotations for water molecules (2 H2O) and a chloride ion (Cl-).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.